• Clinical Insights: November 24, 2020

    Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. Contact us to learn more. New Drug Approval ZokinvyTM (lonafarnib) Capsules – New Drug Approval – November 20, 2020 – The U.S. Food and Drug Administration approved ZokinvyTM (lonafarnib) capsules to reduce the risk of death… Read more »

  • Clinical Insights: November 17, 2020

    Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. Contact us to learn more. New Drug Approval Sutab® (sodium sulfate, magnesium sulfate, and potassium chloride) Tablets – New Drug Approval – November 10, 2020 – Sebela Pharmaceuticals® announced that the U.S. Food and Drug Administration… Read more »

  • Clinical Insights: November 10, 2020

    Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. Contact us to learn more. New Drug Approval SesquientTM (fosphenytoin sodium) Injection – New Drug Approval – November 5, 2020 – Sedor Pharmaceuticals, LLC announced that the U.S. Food and Drug Administration (FDA) has approved SesquientTM… Read more »

  • Clinical Insights: November 4, 2020

    Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. Contact us to learn more. New Drug Approval Bronchitol® (mannitol) Inhalation Powder – New Drug Approval – October 30, 2020 – Chiesi USA, Inc., the U.S. affiliate of Chiesi Farmaceutici S.p.A., an international research-focused healthcare Group… Read more »

  • Clinical Insights: October 27, 2020

    Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. Contact us to learn more. New Drug Approval Veklury® (remdesivir) Injection – New Drug Approval – October 22, 2020 – The U.S. Food and Drug Administration approved the antiviral drug Veklury® (remdesivir) for use in adult… Read more »

  • Clinical Insights: October 20, 2020

    Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. Contact us to learn more. New Drug Approval InmazebTM (atoltivimab, maftivimab, and odesivimab-ebgn) Injection – New Drug Approval – October 14, 2020 – The U.S. Food and Drug Administration approved InmazebTM (atoltivimab, maftivimab, and odesivimab-ebgn), a… Read more »

  • Clinical Insights: October 13, 2020

    Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. Contact us to learn more. New Drug Approval No new update. New Formulation Approval No new update. New Indication/Dosage Approval No new update. New Drug Shortage No new update. New Drug Recall and Safety Alerts No… Read more »

  • Clinical Insights: October 6, 2020

    Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. Contact us to learn more.   New Drug Approval Alkindi® Sprinkle (hydrocortisone) Oral Granules – New Orphan Drug Approval – September 29, 2020 – Eton Pharmaceuticals, Inc, a specialty pharmaceutical company focused on developing and commercializing… Read more »

  • Clinical Insights: September 29, 2020

    Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. Contact us to learn more. New Drug Approval No new update. New Formulation Approval No new update. New Indication/Dosage Approval NucalaTM (mepolizumab) Injection – New Approved Indication – September 25, 2020 – GlaxoSmithKline plc (GSK) announced… Read more »

  • Clinical Insights: September 22, 2020

    Welcome to RxStrategies’ Clinical Insights, designed to help pharmacy professionals stay up to date on the ever-changing pharmaceutical and pharmacy market place. Contact us to learn more. New Drug Approval No new update. New Formulation Approval No new update. New Indication/Dosage Approval No new update. New Drug Shortage September 21, 2020  Indinavir (CRIXIVAN) Capsules (Discontinuation) September 18, 2020 Finasteride… Read more »